Taipei City, Taiwan
Summary
This company focuses on the development and management of new drugs, primarily targeting cancer treatments such as pancreatic cancer, triple-negative breast cancer, and age-related macular degeneration. It also offers ophthalmic diagnostic instruments and health supplements. The business aims to expand its market presence globally while maintaining a commitment to innovation and respect for life.
Based on content on syncorebio.com
bostonscientific.com
Marlborough, Massachusetts
Medical Devices and Healthcare Solutions
eczacibasiilac.com.tr
Istanbul, Turkey
Pharmaceuticals and healthcare products
We offer API access to our data.
7 of 8 checks passed
Label
Value
Active Dates
12.7 years — Since May 2012
Web Hosting
Platform
E-Mail Provider
NAICS Code
325412
SIC 4 Digit Code
2834
SIC 2 Digit Code
28
Industry
1. Pharmaceuticals and Biotechnology
2. Pharmaceutical Preparation Manufacturing
No vendors identified.
Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2012 |
|
|
|
|
|
|
|
|
|
|
|
|
2013 |
|
|
|
|
|
|
|
|
|
|
|
|
2014 |
|
|
|
|
|
|
|
|
|
|
|
|
2015 |
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
|
2017 |
|
|
|
|
|
|
|
|
|
|
|
|
2018 |
|
|
|
|
|
|
|
|
|
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|